Pancreas transplantation with enteroanastomosis to native duodenum poses technical challenges - But offers improved endoscopic access for scheduled biopsies and therapeutic interventions

American Journal of Transplantation

Volumn 15, Issue 1, 2015, Pages 242-250

  Horneland, R ^a   Paulsen, V ^a   Lindahl, J P ^a   Grzyb, K ^a   Eide, T J ^a   Lundin, K ^a   Aabakken, L ^a   Jenssen, T ^a,b   Aandahl, E M ^a,c   Foss, A ^a   Oyen O ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HLA A ANTIGEN; HLA ANTIBODY; HLA B ANTIGEN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DUODENODUODENOSTOMY; DUODENOJEJUNOSTOMY; DUODENOSTOMY; ENDOSCOPIC ECHOGRAPHY; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE ANASTOMOSIS; JEJUNOSTOMY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PANCREAS BIOPSY; PANCREAS DUCT STENOSIS; PANCREAS THROMBOSIS; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATION; REOPERATION; RETROSPECTIVE STUDY; SMALL INTESTINE OBSTRUCTION; SURGICAL TECHNIQUE; TREATMENT DURATION; TREATMENT OUTCOME; ANASTOMOSIS; BIOPSY; CLINICAL TRIAL; DRUG EFFECTS; DUODENUM; ENDOSCOPY; FEASIBILITY STUDY; INTERVENTION STUDY; MORTALITY; PROGNOSIS; SURGERY; SURVIVAL RATE;

ADULT; ANASTOMOSIS, SURGICAL; BIOPSY; DUODENUM; ENDOSCOPY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERVENTION STUDIES; KIDNEY TRANSPLANTATION; MALE; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84919663121     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12953     Document Type: Article

References (18)

1. Gruessner RW, Gruessner AC., The current state of pancreas transplantation. Nat Rev Endocrinol 2013; 9: 555-562.
2. Gruessner AC., 2011 update on pancreas transplantation: Comprehensive trend analysis of 25,000 cases followed up over the course of twenty-four years at the International Pancreas Transplant Registry (IPTR). Rev Diabetic Studies 8: 6-16.
3. Sutherland DE, Gruessner RW, Dunn DL, et al. Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 2001; 233: 463-501.
4. Sollinger HW, Odorico JS, Becker YT, D'Alessandro AM, Pirsch JD., One thousand simultaneous pancreas-kidney transplants at a single center with 22-year follow-up. Ann Surg 2009; 250: 618-630.
5. Rogers J, Farney AC, Al-Geizawi S, et al. Pancreas transplantation: Lessons learned from a decade of experience at Wake Forest Baptist Medical Center. Rev Diabetic Studies 2011; 8: 17-27.
6. Ollinger R, Margreiter C, Bosmuller C, et al. Evolution of pancreas transplantation: Long-term results and perspectives from a high-volume center. Ann Surg 2012; 256: 780-786; discussion 786-787.
7. Margreiter C, Aigner F, Resch T, et al. Enteroscopic biopsies in the management of pancreas transplants: A proof of concept study for a novel monitoring tool. Transplantation 2012; 93: 207-213.
8. Heilman RL, Mazur MJ, Reddy KS., Immunosuppression in simultaneous pancreas-kidney transplantation: Progress to date. Drugs 2010; 70: 793-804.
9. Haas M, Sis B, Racusen LC, et al. Banff 2013 meeting report: Inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 2014; 14: 272-283.
10. Wu T, Abu-Elmagd K, Bond G, Nalesnik MA, Randhawa P, Demetris AJ., A schema for histologic grading of small intestine allograft acute rejection. Transplantation 2003; 75: 1241-1248.
11. Gunasekaran G, Wee A, Rabets J, Winans C, Krishnamurthi V., Duodenoduodenostomy in pancreas transplantation. Clin Transplantation 2012; 26: 550-557.
12. Schenker P, Flecken M, Vonend O, Wunsch A, Traska T, Viebahn R., En bloc retroperitoneal pancreas-kidney transplantation with duodenoduodenostomy using pediatric organs. Transplantation Proc 2009; 41: 2643-2645.
13. Boggi U, Vistoli F, Amorese G, et al. Long-term (5 years) efficacy and safety of pancreas transplantation alone in type 1 diabetic patients. Transplantation 2012; 93: 842-846.
14. Kayler LK, Wen X, Zachariah M, Casey M, Schold J, Magliocca J., Outcomes and survival analysis of old-to-old simultaneous pancreas and kidney transplantation. Transplant Int 2013; 26: 963-972.
15. Finger EB, Radosevich DM, Dunn TB, et al. A composite risk model for predicting technical failure in pancreas transplantation. Am J Transplant 2013; 13: 1840-1849.
16. Malaise J, Berney T, Morel P, et al. Effect of HLA matching in simultaneous pancreas-kidney transplantation. Transplantation Proc 2005; 37: 2846-2847.
17. Meier-Kriesche HU, Scornik JC, Susskind B, Rehman S, Schold JD., A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients. Transplantation 2009; 88: 23-29.
18. de Kort H, Mallat MJ, van Kooten C, et al. Diagnosis of early pancreas graft failure via antibody-mediated rejection: Single-center experience with 256 pancreas transplantations. Am J Transplant 2014; 14: 936-942.